Sacu, Stefan
2 papers on CoChatORCID 0000-0002-4920-2231
Most cited papers
- Verified
Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials
Heier, J. S., Khanani, A. M., Quezada Ruiz, C., Basu, K., Ferrone, P. J., Brittain, C., Figueroa, M. S., Lin, H., Holz, F. G., Patel, V., et al. (2022) · The Lancet
Retinal Diseases and TreatmentsOcular Diseases and Behçet’s Syndrome
Cited by 785
- Verified
2018 Update on Intravitreal Injections: Euretina Expert Consensus Recommendations
Grzybowski, A., Told, R., Sacu, S., Bandello, F., Moisseiev, E., Loewenstein, A., Schmidt-Erfurth, U., & on behalf of the Euretina Board (2018) · Ophthalmologica
Retinal Diseases and TreatmentsRetinal and Macular Surgery
Cited by 297
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free